Skip to main content

Table 1 The characteristics of CAD patients and controls

From: Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population

Characteristics CAD (n = 626) Controls (n = 470) χ2(t) P
Age (years) 64.18 ± 9.83 61.62 ± 9.42 4.337 < 0.01
Male [n (%)] 439 (70.13) 243 (51.70) 38.774 < 0.01
EH [n (%)] 454 (72.52) 276 (58.72) 22.986 < 0.01
DM [n (%)] 163 (26.04) 67 (14.26) 22.478 < 0.01
Smoking [n (%)] 239 (38.18) 114 (24.26) 23.835 < 0.01
TC (mmol/l) 4.59 ± 1.05 4.42 ± 0.96 2.807 < 0.01
TG (mmol/l) 1.84 ± 1.50 1.76 ± 1.46 0.949 > 0.05
HDL-C (mmol/l) 1.08 ± 0.27 1.16 ± 0.31 4.752 < 0.01
LDL-C (mmol/l) 2.93 ± 0.92 2.64 ± 0.79 5.572 < 0.01
ApoA1 (g/l) 1.18 ± 0.23 1.23 ± 0.24 3.691 < 0.01
ApoB (g/l) 1.16 ± 0.31 1.08 ± 0.27 3.789 < 0.01
  1. CAD coronary artery disease, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, EH essential hypertension, DM diabetes mellitus